Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
Fuji
Harvard Business School
Moodys
Accenture
Daiichi Sankyo
Deloitte
Medtronic
Citi

Generated: February 21, 2018

DrugPatentWatch Database Preview

Valdecoxib - Generic Drug Details

« Back to Dashboard

What are the generic sources for valdecoxib and what is the scope of valdecoxib freedom to operate?

Valdecoxib
is the generic ingredient in one branded drug marketed by Gd Searle and is included in one NDA. Additional information is available in the individual branded drug profile pages.

US Patents and Regulatory Information for valdecoxib

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-003 Nov 16, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-002 Nov 16, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for valdecoxib

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-002 Nov 16, 2001 ➤ Sign Up ➤ Sign Up
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-003 Nov 16, 2001 ➤ Sign Up ➤ Sign Up
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-002 Nov 16, 2001 ➤ Sign Up ➤ Sign Up
Gd Searle BEXTRA valdecoxib TABLET;ORAL 021341-003 Nov 16, 2001 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Chinese Patent Office
AstraZeneca
Argus Health
UBS
Teva
US Department of Justice
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot